Sialoadhesin

SIGLEC1
Identifiers
AliasesSIGLEC1, CD169, SIGLEC-1, SN, dJ1009E24.1, sialic acid binding Ig like lectin 1
External IDsOMIM: 600751; MGI: 99668; GeneCards: SIGLEC1
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

6614

20612

Ensembl

ENSG00000088827

ENSMUSG00000027322

UniProt

Q9BZZ2

Q62230

RefSeq (mRNA)

NM_023068
NM_001367089

NM_011426

RefSeq (protein)

NP_075556
NP_001354018

NP_035556

Location (UCSC)Chr 20: 3.69 – 3.71 MbChr 2: 130.91 – 130.93 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse
Sialoadhesin
Structure of the N-terminal domain of sialoadhesin.
Identifiers
SymbolSIGLEC1
Alt. symbolsSN, CD169
NCBI gene6614
HGNC11127
OMIM600751
PDB2BVE
RefSeqNM_023068
UniProtQ9BZZ2
Other data
LocusChr. 20 p13
Search for
StructuresSwiss-model
DomainsInterPro

Sialoadhesin (SIGLEC-1) is a cell adhesion molecule found on the surface of various immune cells. It is found in especially high amounts on macrophages of the spleen, liver, lymph node, bone marrow, colon, and lungs.

Soluble SIGLEC-1 is a biomarker of monocyte-macrophage activation in systemic lupus erythematosus (SLE) and other autoimmune disorders. In patients with rheumatoid arthritis, the protein has been found in great amounts on macrophages of the affected tissues. It is defined as an I-type lectin, since it contains 17 immunoglobulin (Ig) domains (one variable domain and 16 constant domains), and thus also belongs to the immunoglobulin superfamily (IgSF).

Sialoadhesin binds to certain molecules called sialic acids. During this binding process a salt bridge is formed between a highly conserved arginine residue (in the V-set domain) and the carboxylate group of the sialic acid. Since sialoadhesin binds sialic acids with its N-terminal IgV-domain, it is also a member of the Siglec family. Alternate names for sialoadhesin include siglec-1 and CD169 (cluster of differentiation 169).

Sialoadhesin predominantly binds neutrophils, but can also bind monocytes, natural killer cells, B cells and a subset of cytotoxic T cells by interacting with sialic acid molecules in the ligands on their surfaces.